BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19070795)

  • 1. [Chemotherapy indications in the treatment of metastases from urological malignancies].
    Théodore C
    Prog Urol; 2008 Nov; 18 Suppl 7():S219-22. PubMed ID: 19070795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving role of chemotherapy in advanced urothelial cancer.
    Calabrò F; Sternberg CN
    Curr Opin Support Palliat Care; 2007 Oct; 1(3):180-6. PubMed ID: 18685360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy indications in the treatment of metastases from urological malignancies].
    Nguyen TD; Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S223-7. PubMed ID: 19070796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel agents for muscle-invasive and advanced urothelial cancer.
    Sonpavde G; Ross R; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Lerner SP; Sternberg CN
    BJU Int; 2008 Apr; 101(8):937-43. PubMed ID: 18005203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urological cancer].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):193-8. PubMed ID: 19223735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncogeriatric evaluation for elderly patients suffering from metastatic urologic malignancies].
    Neuzillet Y; Méjean A; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S415-25. PubMed ID: 19070825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
    Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
    Bamias A
    Eur Urol; 2007 Oct; 52(4):1113-4. PubMed ID: 17367916
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrating metastasectomy in the management of advanced urological malignancies-where are we in 2005?
    Rasco DW; Assikis V; Marshall F
    J Urol; 2006 Nov; 176(5):1921-6. PubMed ID: 17070212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic therapy for metastatic urothelial carcinoma.
    Lin CC; Hsu CH; Pu YS; Vogelzang NJ
    BJU Int; 2008 Apr; 101(7):795-803. PubMed ID: 18070193
    [No Abstract]   [Full Text] [Related]  

  • 11. [Surgery for thoracic metastases from urological malignancies].
    Chapelier A
    Prog Urol; 2008 Nov; 18 Suppl 7():S250-5. PubMed ID: 19070801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role and technical aspects of surgery for spinal metastases from urological malignancies].
    Gaillard S; Lepeintre JF; Aldea S; Scarone P; Méjean A; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S239-45. PubMed ID: 19070799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of advanced urological tumors].
    Krege S
    Onkologie; 2003 Oct; 26 Suppl 4():13-7. PubMed ID: 14605451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the pathologist in the diagnosis of metastases from urological malignancies].
    Molinié V
    Prog Urol; 2008 Nov; 18 Suppl 7():S178-95. PubMed ID: 19070790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line therapies in metastatic urothelial carcinoma.
    Narayanan S; Harshman LC; Srinivas S
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):341-59, x. PubMed ID: 25836939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The imaging aspects of metastases from urological malignancies].
    Correas JM; Méjean A; Hélénon O
    Prog Urol; 2008 Nov; 18 Suppl 7():S196-201. PubMed ID: 19070791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies for urothelial cancer.
    Serrano C; Morales R; Suárez C; Núñez I; Valverde C; Rodón J; Humbert J; Padrós O; Carles J
    Cancer Treat Rev; 2012 Jun; 38(4):311-7. PubMed ID: 22113129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of brain metastases from urological malignancies].
    Gaillard S; Lebret T; Scarone P; Lepeintre JF; Méjean A; Aldea S
    Prog Urol; 2008 Nov; 18 Suppl 7():S234-8. PubMed ID: 19070798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What are the contributions of experimental studies to the diagnosis and therapy of urological tumors?].
    Debruyne FM; Oosterhof GO; Schalken JA
    Verh K Acad Geneeskd Belg; 1991; 53(1):29-37; discussion 38. PubMed ID: 2053419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.